Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
NICE guidance recommends considering these medications for specific clinical scenarios where multiple metabolic abnormalities coexist
The combination is not FDA-approved
In October 2019, the United States Food and Drug Administration (FDA) approved MT1 under the brand name Scenesse for increasing sunlight tolerance and alleviating pain from ultraviolet (UV) light exposure in patients with erythropoietic protoporphyria (EPP) [4]
Store the unopened vial at 2 to 8 degrees Celsius for up to 24 months, protected from light
US$ 22.46
.png)
US$ 26.84
US$ 20.62
US$ 20.22
